ACELYRIN, Inc.
DelistedCIK 1962918fmd_1AXDBQNANZJFKBGJ33TBVKNGHAManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2021 to Mar 31, 2025, 14 periods
Latest annual · FY2024
Millions- Operating income
- (316)
- Net income
- (248)
- Free cash flow
- (305)
Latest quarter · Q1 FY2025
Millions- Operating income
- (60)
- Net income
- (55)
- Free cash flow
- (39)
ACELYRIN, Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2024 | FY2023 | Change | Source |
|---|---|---|---|---|
| Operating income | -$316.3 million | -$422.1 million | 10-K 2025-03-19 · proof | |
| Net income | -$248.2 million | -$381.6 million | 10-K 2025-03-19 · proof | |
| Cash from operating activities | -$303.9 million | -$169.7 million | 10-K 2025-03-19 · proof | |
| Free cash flow | -$305.2 million | -$172 million | 10-K 2025-03-19 · proof | |
| Total assets | $491.1 million | $742.7 million | -33.9% | 10-K 2025-03-19 · proof |
| Total liabilities | $32.8 million | $86.4 million | -62% | 10-K 2025-03-19 · proof |
| Cash and cash equivalents | $73.9 million | $218.1 million | -66.1% | 10-K 2025-03-19 · proof |
- What was ACELYRIN, Inc.'s operating income in fiscal 2024?
- ACELYRIN, Inc. reported operating income of -$316.3 million for fiscal 2024 (the year ended Dec 31, 2024), against -$422.1 million the year before. Source: the 10-K filed with the SEC on Mar 19, 2025. SEC
- What was ACELYRIN, Inc.'s net income in fiscal 2024?
- ACELYRIN, Inc. reported net income of -$248.2 million for fiscal 2024 (the year ended Dec 31, 2024), against -$381.6 million the year before. Source: the 10-K filed with the SEC on Mar 19, 2025. SEC
- What was ACELYRIN, Inc.'s cash from operating activities in fiscal 2024?
- ACELYRIN, Inc. reported cash from operating activities of -$303.9 million for fiscal 2024 (the year ended Dec 31, 2024), against -$169.7 million the year before. Source: the 10-K filed with the SEC on Mar 19, 2025. SEC
- What was ACELYRIN, Inc.'s free cash flow in fiscal 2024?
- ACELYRIN, Inc. reported free cash flow of -$305.2 million for fiscal 2024 (the year ended Dec 31, 2024), against -$172 million the year before. Source: the 10-K filed with the SEC on Mar 19, 2025. SEC
- What are ACELYRIN, Inc.'s total assets?
- As of Dec 31, 2024, ACELYRIN, Inc. reported total assets of $491.1 million, against $742.7 million a year earlier (-33.9%). Source: the 10-K filed with the SEC on Mar 19, 2025. SEC
- What are ACELYRIN, Inc.'s total liabilities?
- As of Dec 31, 2024, ACELYRIN, Inc. reported total liabilities of $32.8 million, against $86.4 million a year earlier (-62%). Source: the 10-K filed with the SEC on Mar 19, 2025. SEC
- What are ACELYRIN, Inc.'s cash and cash equivalents?
- As of Dec 31, 2024, ACELYRIN, Inc. reported cash and cash equivalents of $73.9 million, against $218.1 million a year earlier (-66.1%). Source: the 10-K filed with the SEC on Mar 19, 2025. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1962918&period_type=annual&limit=5"Information only, not investment advice.